about Ovid’s new research content and
where Ovid is across the globe at industry conferences and events worldwide.
Are you affiliated with a leading medical or
If so, send your librarian an email recommending titles
you’ve found valuable for research at your institution.
Interaction of human heat shock protein 70 with tumor-associated peptides.
Biological Chemistry. 390(4):305-312, April 2009.
Pandya, Maya J. 1,2,a,*; Bendz, Henriette 3; Manzenrieder, Florian 2,4; Noessner, Elfriede 5; Kessler, Horst 2,4; Buchner, Johannes 2; Issels, Rolf D. 1,3
Molecular chaperones of the heat shock protein 70 (Hsp70) family play a crucial role in the presentation of exogenous antigenic peptides by antigen-presenting cells (APCs). In a combined biochemical and immuno-logical approach, we characterize the biochemical interaction of tumor-associated peptides with human Hsp70 and show that the strength of this interaction determines the efficacy of immunological cross-presentation of the antigenic sequences by APCs. A fluorescein-labeled cytosolic mammalian Hsc70 binding peptide is shown to interact with human Hsp70 molecules with high affinity (Kd=0.58 [mu]M at 25[degrees]C). Competition experiments demonstrate weaker binding by Hsp70 of antigenic peptides derived from the tumor-associated proteins tyrosinase (Kd=32 [mu]M) and melanoma antigen recognized by T cells (MART-1) (Kd=2.4 mM). Adding a peptide sequence (pep70) with high Hsp70 binding affinity (Kd=0.04 mM) to the tumor-associated peptides enables them to strongly interact with Hsp70. Presentation of tumor-associated peptides by B cells resulting in T cell activation in vitro is enhanced by Hsp70 when the tumor-associated peptides contain the Hsp70 binding sequence. This observation has relevance for vaccine design, as augmented transfer of tumor-associated antigens to APCs is closely linked to the vaccine's efficacy of T cell stimulation.
Copyright (C) 2009 Walter de Gruyter